Most Clicked StoriesMore >
Phase III study is set for stem cell treatment of blood cancers
AABB SmartBrief | Feb 15, 2012
Enrollment has been completed for a 100-patient Phase III clinical trial of StemEx, a cell therapy for patients with blood cancers who cannot find a bone marrow match, Teva Pharmaceutical Industries and Gamida Cell have announced. The companies' joint venture is planning to market StemEx next year. Globes (Israel) (02/14)
Device industry stakeholders testify on MDUFMA
AABB SmartBrief | Feb 16, 2012
Trials of marrow transplant method set for sickle cell disease
AABB SmartBrief | Feb 13, 2012
Patients' own heart cells used to treat cardiac scars
AABB SmartBrief | Feb 14, 2012
Minnesota brings HIPAA action against business associate
AABB SmartBrief | Feb 13, 2012
Fla. hospital uses platelet-rich plasma treatments
AABB SmartBrief | Feb 15, 2012
Experts release guidelines for VTE prevention in nonsurgical patients
AABB SmartBrief | Feb 13, 2012
Obama budget includes $300 billion Medicare cut
AABB SmartBrief | Feb 14, 2012
Factors to consider in giving patients access to data
AABB SmartBrief | Feb 14, 2012
Researchers develop blood test for the early diagnosis of cancer
AABB SmartBrief | Feb 13, 2012
Find AABB SmartBrief Issues by Date:
AABB News
More >
AABB developing sample informed consent form for tissue transplantation
AABB SmartBrief | Feb 17, 2012
Latest issue of AABB News looks at ways to improve quality internationally
AABB SmartBrief | Feb 16, 2012
Annual AABB committee Transition Renewal Process for 2012-13 now open
AABB SmartBrief | Feb 15, 2012
Reminder: Free shipping offered through Feb. 24 on all AABB Marketplace publications
AABB SmartBrief | Feb 14, 2012
Audioconference focuses on preventing reactions in first time and high school donors
AABB SmartBrief | Feb 13, 2012
Sign up for AABB SmartBrief
